Zdravko A. Kamenov

1 GeorgiSofiiski Str
Sofia, 1431, Bulgaria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications

Role of Alpha-Defensins 3 and 5 in Diabetic Complications: Associations with Nephropathy and Metabolic Parameters in Type 2 Diabetes.

Role of Alpha-Defensins 3 and 5 in Diabetic Complications: Associations with Nephropathy and Metabolic Parameters in Type 2 Diabetes.

Journal: Metabolites
Published: July 18, 2026

Angiopoietin-like Proteins 4 and 8 in Diabetic Complications: Associations with Neuropathy and Metabolic Parameters in Type 2 Diabetes.

Angiopoietin-like Proteins 4 and 8 in Diabetic Complications: Associations with Neuropathy and Metabolic Parameters in Type 2 Diabetes.

Journal: Journal of clinical medicine
Published: April 10, 2026

GPIHBP1 as a Biomarker of Diabetic Polyneuropathy and Vascular Complications in Type 2 Diabetes Mellitus.

GPIHBP1 as a Biomarker of Diabetic Polyneuropathy and Vascular Complications in Type 2 Diabetes Mellitus.

Journal: Biomolecules
Published: March 30, 2026

Growth Differentiation Factor-15 as a Biomarker of Diabetic Complications in Patients with Type 2 Diabetes.

Growth Differentiation Factor-15 as a Biomarker of Diabetic Complications in Patients with Type 2 Diabetes.

Journal: Journal of clinical medicine
Published: March 18, 2026

Corneal Confocal Microscopy as a Non-Invasive Marker of Small Fiber Neuropathy and Systemic Complications in Type 2 Diabetes: A Cross-Sectional Study.

Corneal Confocal Microscopy as a Non-Invasive Marker of Small Fiber Neuropathy and Systemic Complications in Type 2 Diabetes: A Cross-Sectional Study.

Journal: Biomolecules
Published: March 03, 2026

Circulating Neopterin Is Independently Associated with Autonomic Neuropathy in Type 2 Diabetes, but Not with Other Microvascular Complications.

Circulating Neopterin Is Independently Associated with Autonomic Neuropathy in Type 2 Diabetes, but Not with Other Microvascular Complications.

Journal: Medical sciences (Basel, Switzerland)
Published: February 27, 2026

Distinct Gut Microbiome Profiles Underlying Cardiometabolic Risk Phenotypes in Individuals with Obesity.

Distinct Gut Microbiome Profiles Underlying Cardiometabolic Risk Phenotypes in Individuals with Obesity.

Journal: Nutrients
Published: December 24, 2025

Expression of miR-210-3p as a Prognostic Marker for Development of Diabetic Neuropathy.

Expression of miR-210-3p as a Prognostic Marker for Development of Diabetic Neuropathy.

Journal: Metabolites
Published: November 06, 2025

Berardinelli-Seip syndrome.

Berardinelli-Seip syndrome.

Journal: Endokrynologia Polska
Published: August 28, 2025

New Players in Metabolic Syndrome.

New Players in Metabolic Syndrome.

Journal: Metabolites
Published: May 04, 2025

New Markers for the Assessment of Microvascular Complications in Patients with Metabolic Syndrome.

New Markers for the Assessment of Microvascular Complications in Patients with Metabolic Syndrome.

Journal: Metabolites
Published: February 06, 2025

Levels of DEFA1, Progranulin, and NRG4 in Patients with Autonomic Neuropathy: Potential Biomarkers for Diagnosis and Prognosis.

Levels of DEFA1, Progranulin, and NRG4 in Patients with Autonomic Neuropathy: Potential Biomarkers for Diagnosis and Prognosis.

Journal: Metabolites
Published: January 27, 2025
Showing 1-12 of 102

Last Updated: 09/26/2026